Novavax Files COVID-19 Vaccine Candidate With UK Regulator
Product Still Under Rolling Review In EU
The company says it expects a “positive decision” on the first approval application for a protein-based coronavirus vaccine in the UK. If approved, NVX-CoV2373 would become the fifth COVID-19 jab to reach the market there.
